These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1561 related items for PubMed ID: 24930082

  • 1. [Diuretic therapy in acute heart failure].
    Trullàs JC, Morales-Rull JL, Formiga F.
    Med Clin (Barc); 2014 Mar; 142 Suppl 1():36-41. PubMed ID: 24930082
    [Abstract] [Full Text] [Related]

  • 2. In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function.
    De Vecchis R, Ciccarelli A, Ariano C, Cioppa C, Giasi A, Pucciarelli A, Cantatrione S.
    Minerva Cardioangiol; 2011 Dec; 59(6):543-54. PubMed ID: 21330961
    [Abstract] [Full Text] [Related]

  • 3. [Diuretic therapy in heart failure].
    Trullàs JC, Morales-Rull JL, Formiga F, en representación del Grupo de Trabajo de Insuficiencia Cardiaca y Fibrilación Auricular de la Sociedad Española de Medicina Interna.
    Med Clin (Barc); 2014 Feb 20; 142(4):163-70. PubMed ID: 23768854
    [Abstract] [Full Text] [Related]

  • 4. [Value of aldosterone receptor blockade in diuretic therapy of patients with chronic heart failure].
    Christ M, Ludwig N, Maisch B.
    Herz; 2002 Mar 20; 27(2):135-49. PubMed ID: 12025459
    [Abstract] [Full Text] [Related]

  • 5. Combining Loop and Thiazide Diuretics Across the Left Ventricular Ejection Fraction Spectrum: The CLOROTIC Trial.
    Sánchez-Marteles M, Garcés-Horna V, Morales-Rull JL, Casado J, Carrera-Izquierdo M, Conde-Martel A, Dávila-Ramos MF, Llácer P, Salamanca-Bautista P, Ruiz R, Aramburu-Bodas O, Formiga F, Manzano L, Trullàs JC.
    JACC Heart Fail; 2024 Oct 20; 12(10):1719-1730. PubMed ID: 38934966
    [Abstract] [Full Text] [Related]

  • 6. Thiazide diuretics versus loop diuretics in stage 3-5 CKD: impact on cardiorenal outcomes.
    Sung LC, Chiu HW, Yu SM, Tsou LL, Hsu YH, Wu MS, Lin CL, Tsai FJ, Chou CL.
    Postgrad Med; 2024 Sep 20; 136(7):738-748. PubMed ID: 39189768
    [Abstract] [Full Text] [Related]

  • 7. Comparison of the effects of combination diuretic therapy with oral hydrochlorothiazide or intravenous chlorothiazide in patients receiving intravenous furosemide therapy for the treatment of heart failure.
    Kissling KT, Pickworth KK.
    Pharmacotherapy; 2014 Aug 20; 34(8):882-7. PubMed ID: 24990816
    [Abstract] [Full Text] [Related]

  • 8. [Alternatives to conventional diuretic therapy in heart failure].
    Morales-Rull JL, Trullàs JC, Formiga F.
    Med Clin (Barc); 2014 Mar 20; 142 Suppl 1():42-8. PubMed ID: 24930083
    [Abstract] [Full Text] [Related]

  • 9. Combination of loop diuretics with thiazide-type diuretics in heart failure.
    Jentzer JC, DeWald TA, Hernandez AF.
    J Am Coll Cardiol; 2010 Nov 02; 56(19):1527-34. PubMed ID: 21029871
    [Abstract] [Full Text] [Related]

  • 10. Metabolic and toxicological considerations for diuretic therapy in patients with acute heart failure.
    Aspromonte N, Cruz DN, Valle R, Bonello M, Tubaro M, Gambaro G, Marchese G, Santini M, Ronco C.
    Expert Opin Drug Metab Toxicol; 2011 Sep 02; 7(9):1049-63. PubMed ID: 21599566
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Use of natriuretic-doses of spironolactone for treatment of loop diuretic resistant acute decompensated heart failure.
    Eng M, Bansal S.
    Int J Cardiol; 2014 Jan 01; 170(3):e68-9. PubMed ID: 24268982
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Higher doses of loop diuretics limit uptitration of angiotensin-converting enzyme inhibitors in patients with heart failure and reduced ejection fraction.
    Ter Maaten JM, Martens P, Damman K, Dickstein K, Ponikowski P, Lang CC, Ng LL, Anker SD, Samani NJ, Filippatos G, Cleland JG, Zannad F, Hillege HL, van Veldhuisen DJ, Metra M, Voors AA, Mullens W.
    Clin Res Cardiol; 2020 Aug 01; 109(8):1048-1059. PubMed ID: 32002631
    [Abstract] [Full Text] [Related]

  • 18. Effect of admission oral diuretic dose on response to continuous versus bolus intravenous diuretics in acute heart failure: an analysis from diuretic optimization strategies in acute heart failure.
    Shah RV, McNulty S, O'Connor CM, Felker GM, Braunwald E, Givertz MM.
    Am Heart J; 2012 Dec 01; 164(6):862-8. PubMed ID: 23194486
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Combination of high-dose furosemide and hydrochlorothiazide in the treatment of refractory congestive heart failure.
    Dormans TP, Gerlag PG.
    Eur Heart J; 1996 Dec 01; 17(12):1867-74. PubMed ID: 8960430
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 79.